Clinical impact of double-faecal immunochemical testing following implementation into standard triage and investigation of primary care referrals in patients with lower gastrointestinal symptoms
The double-faecal immunochemical testing pathway demonstrated high test return rates, a reduction in unnecessary investigations, and colorectal cancer detection rates similar to preimplementation rates.
Authors
- Yasuko Maeda (ORCID: https://orcid.org/0000-0002-4081-4741)
- Alastair Thomson (ORCID: https://orcid.org/0000-0001-6666-1088)
- Malcolm G. Dunlop (ORCID: https://orcid.org/0000-0002-3033-5851)
- Frances Gunn
- Farhat V N Din (ORCID: https://orcid.org/0000-0001-5466-8282)
- Adam Daniel Gerrard (ORCID: https://orcid.org/0000-0001-5649-9240)
- Rebecca Cheesbrough
- Colin Noble
- L. Arlene Porteous
Institutions
- NHS Lothian (GB)
- Western General Hospital (GB)
- Edinburgh Cancer Research (GB)
- Queen Elizabeth University Hospital (GB)
- University of Glasgow (GB)
Publication Details
- Journal
- BJS Open
- Published
- 2025-09-08
- DOI
- https://doi.org/10.1093/bjsopen/zraf098
- Primary Topic
- Microscopic Colitis
- Type
- article
- Field-Weighted Citation Impact
- 0.00